Cargando…
The Therapeutic Strategy of HDAC6 Inhibitors in Lymphoproliferative Disease
Histone deacetylases (HDACs) are master regulators of chromatin remodeling, acting as epigenetic regulators of gene expression. In the last decade, inhibition of HDACs has become a target for specific epigenetic modifications related to cancer development. Overexpression of HDAC has been observed in...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121661/ https://www.ncbi.nlm.nih.gov/pubmed/30096875 http://dx.doi.org/10.3390/ijms19082337 |